Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonclassical nicotine antagonists.

C F Barfknecht, C A Taylor

    Journal of Medicinal Chemistry
    |November 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Researchers synthesized novel nicotine antagonists and found compound 2 to be the most potent. Structure-activity relationships revealed bisquaternary compounds and those with two phenyl rings were generally more effective than classical antagonists.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Levels of support for legislative bans to end physical punishment in schools and homes in a national sample.

    Public health·2023
    Same author

    Preclinical validation of the advection diffusion flow estimation method using computational patient specific coronary tree phantoms.

    International journal for numerical methods in biomedical engineering·2023
    Same author

    The association of coronary lumen volume to left ventricle mass ratio with myocardial blood flow and fractional flow reserve.

    Journal of cardiovascular computed tomography·2019
    Same author

    Low Dietary Protein Intakes and Associated Dietary Patterns and Functional Limitations in an Aging Population: A NHANES analysis.

    The journal of nutrition, health & aging·2019
    Same author

    Beliefs and ideologies linked with approval of corporal punishment: a content analysis of online comments.

    Health education research·2016
    Same author

    Are the UK systems of innovation and evaluation of medical devices compatible? The role of NICE's Medical Technologies Evaluation Programme (MTEP).

    Applied health economics and health policy·2014
    Same journal

    A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

    Journal of medicinal chemistry·2026
    Same journal

    GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency.

    Journal of medicinal chemistry·2026
    Same journal

    Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

    Journal of medicinal chemistry·2026
    Same journal

    Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

    Journal of medicinal chemistry·2026
    Same journal

    Library Docking for Cannabinoid-2 Receptor Ligands.

    Journal of medicinal chemistry·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Medicinal Chemistry

    Background:

    • Nicotine antagonists are crucial for understanding nicotinic acetylcholine receptors.
    • Classical antagonists like hexamethonium have limitations.
    • Development of novel, potent antagonists is an ongoing research area.

    Purpose of the Study:

    • To synthesize and evaluate a series of novel "nonclassical" nicotine antagonists.
    • To compare the potency of these novel compounds with the classical antagonist hexamethonium.
    • To elucidate structure-activity relationships for this class of compounds.

    Main Methods:

    • Synthesis of a series of bisquaternary and monoquaternary compounds.
    • Pharmacological evaluation using the isolated guinea pig atria preparation.
    • Comparative analysis of antagonist potency.

    Related Experiment Videos

    Main Results:

    • Compound 2 emerged as the most potent antagonist, outperforming hexamethonium.
    • Bisquaternary compounds (1-3, 7-9) were generally more potent than monoquaternary analogs (4, 6, 10-12).
    • Compounds with two phenyl rings exhibited higher potency within specific series.

    Conclusions:

    • Novel nonclassical nicotine antagonists have been developed with significant potency.
    • Structure-activity relationship analysis provides insights into optimal molecular design for nicotinic antagonism.
    • These findings contribute to the development of new therapeutic agents targeting nicotinic acetylcholine receptors.